Breaking News Instant updates and real-time market news.

FTR

Frontier Communications

$8.78

-0.32 (-3.52%)

, FSLR

First Solar

$63.24

2.03 (3.32%)

09:55
12/07/17
12/07
09:55
12/07/17
09:55

Early notable gainers among liquid option names on December 7th

Notable gainers among liquid option names this morning include Frontier Communications (FTR) $9.12 +0.34, First Solar (FSLR) $65.44 +2.21, Dollar General (DG) $93.67 +2.84, Edwards Lifesciences (EW) $116.78 +3.39, and Micron (MU) $42.80 +1.23.

FTR

Frontier Communications

$8.78

-0.32 (-3.52%)

FSLR

First Solar

$63.24

2.03 (3.32%)

DG

Dollar General

$94.26

3.4075 (3.75%)

EW

Edwards Lifesciences

$116.23

2.87 (2.53%)

MU

Micron

$41.58

0.37 (0.90%)

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 19

    Dec

FTR Frontier Communications
$8.78

-0.32 (-3.52%)

11/01/17
11/01/17
DOWNGRADE
Target $8

Underweight
JPMorgan downgrades Frontier Communications, sees dividend cut as likely
As previously reported, JPMorgan analyst Philip Cusick downgraded Frontier Communications to Underweight from Neutral, saying the company reported mostly in-line Q3 earnings but he struggles to see how the company will keep up with competition. Frontier's board voted to pay the December dividend of 60c, "which makes no sense," said Cusick, who believes the board is likely to cut it after that. He lowered his price target to $8 from $17 on Frontier shares, which are down 26% to $8.95 heading into the close.
11/02/17
WELS
11/02/17
NO CHANGE
Target $9
WELS
Market Perform
Frontier Communications price target lowered to $9 from $14.50 at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche lowered her price target for Frontier Communications to $9 from $14.50 after the company reported mixed Q3 results. The analyst reiterates a Market Perform rating on the shares.
11/09/17
GABE
11/09/17
DOWNGRADE
GABE
Hold
Frontier Communications downgraded to Hold from Buy at Gabelli
Gabelli analyst Sergey Dluzhevskiy downgraded Frontier Communications to Hold from Buy telling investors he has increased concerns customer and revenue trends are not improving fast enough for the company to stabilize the business and deliver meaningful results. The analyst expects leverage to remain elevated over the next few years and does not expect the competitive environment to ease. Further, Dluzhevskiy said the dividend faces increased risk of being cut if management decides to reinvest in order to accelerate operating trends and or pays down debt.
11/10/17
11/10/17
DOWNGRADE
Target $4

Underperform
Frontier Communications downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst David Barden downgraded Frontier Communications to Underperform and slashed its price target to $4 from $19 due to dividend concerns. Barden said Frontier is evaluating the dividend quarter to quarter, while trying to reduce net leverage, and cannot assume with certainty that the dividends will get paid.
FSLR First Solar
$63.24

2.03 (3.32%)

12/06/17
NEED
12/06/17
NO CHANGE
Target $70
NEED
Buy
First Solar price target raised to $70 from $65 at Needham
Needham analyst Y. Edwin Mok raised his price target on First Solar to $70 from $65 and kept his Buy rating after the company's analyst day. Mok says the company's commitment to aggressive capacity expansion highlights the growing confidence in the large backlog, positioning First Solar to deliver solid sales and earnings growth beyond the "2018 transitional year". The analyst also notes that investors' focus on the risks around "policy changes, S6 transition and low module pricing" may be overstated.
12/06/17
ROTH
12/06/17
NO CHANGE
ROTH
Tax bill could put 'BEAT' down on U.S. renewables, says Roth Capital
Roth Capital analyst Philip Shen believes the Senate Tax Cuts and Jobs Act includes multiple elements that could negatively affect renewable tax equity capacity, such as a cut in the corporate rate from 35% to 20%, the passage of the Base Erosion Anti-Abuse Tax, or BEAT, without exemptions for solar/wind credits, and a reduction in the number of years the product tax credit could be claimed from 10 down to four years. Near-term, the analyst believes that continued negotiations on the Hill could cause increased volatility for his universe of stocks with direct or indirect exposure to the U.S. solar and wind markets, such as AMSC (AMSC), Broadwind Energy (BWEN), 8point3 Energy (CAFD), Canadian Solar (CSIQ), Daqo New Energy (DQ), Enphase Energy (ENPH), First Solar (FSLR), Hannon Armstrong (HASI), Hanwah Q CELLS (HQCL), JA Solar (JASO), JinkoSolar (JKS), SolarEdge (SEDG), Sky Solar (SKYS), ReneSola (SOL), Sunworks (SUNW), and TPI Composites (TPIC).
12/06/17
BARD
12/06/17
NO CHANGE
Target $69
BARD
Neutral
First Solar shares should trade higher following analyst day, says Baird
Baird analyst Ben Kallo believes First Solar shares should trade higher following the company's analyst day given the company's expected Series 6 capacity ramp and cost reductions in addition to its strong balance sheet, which will allow it to capitalize on long-term opportunities. Kallo maintained his Neutral rating and raised his price target to $69 from $53 on First Solar shares.
12/06/17
COWN
12/06/17
NO CHANGE
Target $77
COWN
Outperform
First Solar price target raised to $77 from $60 at Cowen
Cowen analyst Jeffrey Osborne raised his price target on First Solar to $77 from $60 following the company's analyst day, saying that after the event he is more optimistic on the near-term prospects for the company given the decision to extend Series 4 capacity and its favorable economics compared to competitors. Osborne reiterated his Outperform rating on First Solar shares.
DG Dollar General
$94.26

3.4075 (3.75%)

12/04/17
MOFT
12/04/17
INITIATION
MOFT
Neutral
Dollar General initiated with a Neutral at MoffettNathanson
11/20/17
MKMP
11/20/17
NO CHANGE
Target $96
MKMP
Buy
Dollar General price target raised to $96 from $83 at MKM Partners
MKM Partners analyst Patrick McKeever raised his price target on Dollar General (DG) to $96 and kept his Buy rating ahead of its December 7th earnings, saying both Dollar General and Dollar Tree (DLTR) saw significant comps improvement in the second quarter. McKeever expects more upside going into the holidays as a result of wage gains for the core dollar store customer. The analyst adds that he prefers Dollar General to Dollar Tree due to more attractive valuation as well as his view that its 2.5% SSS forecast may be conservative. McKeever is keeping the latter at Neutral while also raising its price target to $96 from $83.
11/16/17
11/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pandora (P) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying that despite the lack of near-term catalysts, the market underappreciates longer-term factors. 2. Dollar General (DG) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying Dollar General's "long-term profit algorithm" will return in 2018. 3. RH (RH) upgraded to Buy from Neutral at Citi with analyst Geoffrey Small saying the company's initial outlook for 2018 alleviates concerns around the balance sheet and uncertainty regarding demand as the retailer backed off of elevated levels of sales and promotions. 4. Regions Financial (RF) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Ryan Nash saying he sees better than expected net interest margin, improving loan growth and increased capital returns helping Regions reach its efficiency goals in 2018. 5. DSW (DSW) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing momentum in the core women's business and well-controlled inventory levels, which suggest positive inflections are at hand. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/04/17
UBSW
12/04/17
NO CHANGE
Target $99
UBSW
Buy
Dollar General price target raised to $99 from $85 at UBS
UBS analyst Michael Lasser raised his price target on Dollar General to $99 from $85 as he views the top and bottom line growth prospects as attractive. The analyst believes margin pressures likely moderated in Q3 and sees the macro backdrop and management initiatives as helping support the company's comps. Lasser reiterated his Buy rating on Dollar General shares.
EW Edwards Lifesciences
$116.23

2.87 (2.53%)

12/05/17
COWN
12/05/17
NO CHANGE
Target $130
COWN
Outperform
Edwards Lifesciences should be bought ahead of investor day, says Cowen
Cowen analyst Joshua Jennings said he is a buyer of Edwards Lifesciences (EW) ahead of its investor day and Q4 results. He said the delay of Boston Scientific's (BSX) Lotus supports his belief that Edwards' U.S. TAVR franchise will show consistent sequential growth in front of a mid-2019 low-risk approval. He also believes guidance will be conservative. Jennings reiterated his Outperform rating and $130 price target on Edwards Lifesciences shares.
12/04/17
LEER
12/04/17
NO CHANGE
Target $120
LEER
Market Perform
Leerink getting more cautious on Edwards Lifesciences ahead of analyst day
Leerink analyst Danielle Antalffy said she has been getting more cautious on Edwards Lifesciences (EW) shares as they moved up in reaction to the Lotus delay experienced by Boston Scientific (BSX), noting that Edwards management has previously said the company gained little from a Lotus recall in Europe. She also expects Edwards' 2018 sales guidance to fall below the consensus Street view and for its EPS outlook to "to bracket the Street at the high end" at best. Antalffy maintains a Market Perform rating an $120 price target on Edwards shares heading into the event.
12/04/17
LEER
12/04/17
NO CHANGE
LEER
Edwards Lifesciences may issue FY18 guidance below expectations, says Leerink
10/25/17
RHCO
10/25/17
NO CHANGE
Target $124
RHCO
Buy
Edwards Lifesciences price target lowered to $124 from $146 at SunTrust
SunTrust analyst Bruce Nudell lowered his price target on Edwards Lifesciences following Q3 results that contained some "disappointing updates", namely slowing U.S. transcatheter aortic valve replacement - TAVR - growth and a delay in the transcatheter mitral valve replacement program. Nudell keeps a Buy rating on Edwards Lifesciences given his longer term optimism that the TAVR market will reach about $7B by 2025, with some 600K addressable U.S. patients.
MU Micron
$41.58

0.37 (0.90%)

11/28/17
STPT
11/28/17
DOWNGRADE
STPT
Hold
Micron downgraded to Hold from Outperform at Standpoint Research
12/04/17
COWN
12/04/17
NO CHANGE
Target $50
COWN
Outperform
Micron upside not priced into shares, says Cowen
Cowen analyst Karl Ackerman said Micron is expected to show an earnings beat for the November quarter but the upside for the February quarter is not fully priced into the shares. He believes there will be no fundamental change in the next few quarters and near-term pricing is great. Ackerman reiterated his Outperform rating and $50 price target on Micron shares.
11/30/17
DBAB
11/30/17
NO CHANGE
Target $55
DBAB
Buy
Micron price target raised to $55 from $50 at Deutsche Bank
Deutsche Bank analyst Sidney Ho raised his price target for Micron Technology to $55 and maintains a Buy rating on the name. In a research note on Global Memory, analysts at Deutsche Bank said they expect record profit for memory in 2018 as demand-supply remains balanced and net wafer capacity adds remain limited due to capacity loss from conversions. They believe the market is underestimating the impact from greater wafer capacity losses from conversions, especially in NAND, and the inventory sell-down in 2016 that could result in lower memory bit shipments in 2018.
11/28/17
11/28/17
DOWNGRADE

Hold
Micron downgraded to Hold after rally at Standpoint Research
As previously reported, Standpoint Research analyst Ronnie Moas downgraded Micron to Hold from Outperform, saying he no longer sees his second-highest rating as justified following the stock's 138% rally since early December.

TODAY'S FREE FLY STORIES

GPOR

Gulfport Energy

$12.19

-0.52 (-4.09%)

05:22
12/15/17
12/15
05:22
12/15/17
05:22
Upgrade
Gulfport Energy rating change  »

Gulfport Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

, LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

05:20
12/15/17
12/15
05:20
12/15/17
05:20
Recommendations
Campbell Soup, Snyder's-Lance analyst commentary  »

Campbell deal for…

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.87

0.84 (1.01%)

05:16
12/15/17
12/15
05:16
12/15/17
05:16
Recommendations
Tesaro analyst commentary  »

Tesaro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:13
12/15/17
12/15
05:13
12/15/17
05:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRC

First Republic

$88.54

-0.27 (-0.30%)

05:11
12/15/17
12/15
05:11
12/15/17
05:11
Downgrade
First Republic rating change  »

First Republic downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.87

0.84 (1.01%)

05:10
12/15/17
12/15
05:10
12/15/17
05:10
Hot Stocks
Tesaro announces availability of Zejula in Germany »

Tesaro announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$31.11

0.05 (0.16%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Hot Stocks
Hutchison China MediTech initiates fruquintinib U.S. clinical trials »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

, CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Recommendations
Snyder's-Lance, Campbell Soup analyst commentary  »

Snyder's-Lance worth…

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$57.31

-0.38 (-0.66%)

05:07
12/15/17
12/15
05:07
12/15/17
05:07
Hot Stocks
CSX announces medical leave of CEO, COO James Foote named acting CEO »

CSX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:03
12/15/17
12/15
05:03
12/15/17
05:03
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:00
12/15/17
12/15
05:00
12/15/17
05:00
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SON

Sonoco Products

$53.13

-0.6 (-1.12%)

04:59
12/15/17
12/15
04:59
12/15/17
04:59
Upgrade
Sonoco Products rating change  »

Sonoco Products upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

, AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

04:58
12/15/17
12/15
04:58
12/15/17
04:58
Upgrade
Sealed Air, Avery Dennison rating change  »

Sealed Air upgraded to…

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.80

-0.1 (-0.92%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Initiation
Hi-Crush Partners initiated  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.49

-0.35 (-0.66%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
MetLife to hold a conference call »

Investor outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

  • 12

    Jun

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

November Industrial…

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Breaking General news story  »

Week of 12/15…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Cable, Media &…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

DIS

Disney

$110.57

2.96 (2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production to be reported at 09:15 »

November Industrial…

ADRNY

Ahold Delhaize

$21.69

-0.14 (-0.64%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Ahold Delhaize management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

BASFY

BASF

$27.57

-0.17 (-0.61%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
BASF management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

CUTR

Cutera

$47.20

-1.3 (-2.68%)

, TESO

Tesco

$3.70

-0.25 (-6.33%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Hot Stocks
Cutera to replace Tesco in S&P 600 at open on 12/15 »

MidCap 400 constituent…

CUTR

Cutera

$47.20

-1.3 (-2.68%)

TESO

Tesco

$3.70

-0.25 (-6.33%)

NBR

Nabors Industries

$5.58

-0.23 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

RCKZF

Rocket Internet

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Rocket Internet management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

PJT

PJT Partners

$44.10

-0.24 (-0.54%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
PJT Partners management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.